申请人:Bristol-Myers Squibb Company
公开号:US20140050695A1
公开(公告)日:2014-02-20
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
本公开涉及用于治疗丙型肝炎病毒(HCV)感染的化合物、组合物和方法。还公开了含有这些化合物的制药组合物以及使用这些化合物治疗HCV感染的方法。